Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Vaccine Experts Offer Solutions to Support Vaccine Innovation, Access

Published: Tuesday, April 23, 2013
Last Updated: Tuesday, April 23, 2013
Bookmark and Share
Peer-reviewed article in Vaccine offers actions for bringing vaccines to 90% of the world.

Top vaccine experts provided recommendations for improving global access to and use of high-quality, safe and effective vaccines in a new peer-reviewed paper published in the journal Vaccine.

"Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines," was authored by vaccine experts with support from the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the Biotechnology Industry Organization (BIO).

The research-based article offers proven approaches to achieving equitable and sustained access to vaccines, including

•    Offering insights on achieving the Decade of Vaccine's goal of 90% global vaccine coverage by 2020
•    Addressing the 4As of vaccine access - availability, affordability, adoption and alliances
•    Increasing awareness, predictable demand, and sustainable financing among recommendations to support vaccine access and innovation

According to the authors, accelerating vaccine access and innovation, especially in the developing world, requires a mix of “push and pull” mechanisms. “Push” mechanisms to stimulate R&D are grants and investment tax credits, while “pull” mechanisms can include donor guarantees of vaccine purchases and government programs to promote vaccine uptake through increased awareness of vaccines' health benefits.

“Global health stakeholders from civil society and the public and private sectors share responsibility for achieving the goals of the Decade of Vaccines," says Eduardo Pisani, IFPMA Director General. “This report applies industry learnings and expertise that contributed to several past health successes such as dramatically reduced measles-related deaths and eradication of smallpox. With greater public awareness and access to innovative vaccines, great strides can be made toward preventing other leading communicable and non-communicable diseases.”

“These innovative approaches to achieving equitable and sustained global access to high quality, safe and effective vaccines can potentially save millions of lives, dramatically enhance economic productivity, and reduce under-five mortality,” said Jim Greenwood, BIO’s President and CEO.

Launched in 2010, the Decade of Vaccines (DoV) Initiative assembles key stakeholders from the global health community in an effort to reduce vaccine-preventable illnesses by achieving 90 percent global vaccine coverage by 2020. The paper provides the perspectives of the research-based vaccine industry on how to advance the DoV’s objectives and support vaccine uptake.

Over the last 30 years, vaccine development has accelerated due to scientific breakthroughs in biotechnology, genetic decoding and information technology. The result is a broad range of new vaccines targeting 25 infectious disease categories. Today, vaccines are helping to combat major life-threatening diseases including cervical cancer, which affects 500,000 women each year, and pneumococcal disease, responsible for 1.6 million deaths each year.

Despite important health advances associated with vaccines innovation, barriers to equitable and sustained global access remain. As the global community strives to address those barriers, the authors warn against interventions that fail to reconcile the needs of both access and innovation. The paper highlights the need for “win-wins” for governments, business and society.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!